ZLB
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Mar 2005)
What this means for you
This application is over — abandoned 03 Mar 2005. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 76331795
- Mark type
- Design + words
- Filed
- 29 Oct 2001
- Published for opposition
- 09 Dec 2003
- Abandoned
- 03 Mar 2005
- Attorney of record
- JOHN R. GARBER
Goods and services
- Class 001 — Chemicals: CHEMICAL REAGENTS FOR INDUSTRIAL, SCIENTIFIC AND MEDICAL RESEARCH USE; SERA FOR SCIENTIFIC, INDUSTRIAL AND MEDICAL RESEARCH, NAMELY, THE PRODUCTION OF PHARMACEUTICALS, VACCINES, MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS; SERA ALTERNATIVES IN THE NATURE OF BIOCHEMICALS, NAMELY, PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES FOR USE IN CELL CULTURE SCIENTIFIC RESEARCH; BIOLOGICALS, NAMELY PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES DERIVED FROM BACTERIA VIRUSES AND ANIMALS, FOR USE AS DILUENTS IN CELL CULTURE SCIENTIFIC RESEARCH APPLICATIONS; SERA PRODUCTS IN THE NATURE OF BIOLOGICALS, NAMELY, PRECURSORS, MONOCLONAL ANTIBODIES, POLYPEPTIDES, DERIVED FROM BACTERIAL VIRUSES AND ANIMALS, FOR USE AS DILUENTS IN CELL CULTURE SCIENTIFIC RESEARCH APPLICATIONS; DIAGNOSTIC CHEMICAL AND BIOLOGICAL REAGENTS FOR SCIENTIFIC, INDUSTRIAL OR MEDICAL RESEARCH USE; BIOCHEMICALS, NAMELY, MONOCLONAL ANTIBODIES USED FOR IN VITRO SCIENTIFIC OR RESEARCH USE; CELL CULTURE MEDIA FOR SCIENTIFIC, LABORATORY OR MEDICAL RESEARCH, NAMELY, CELL MEDIA FOR USE IN THE PRODUCTION OF PHARMACEUTICALS, VACCINES, MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS
- Class 005 — Pharmaceuticals: DIAGNOSTIC REAGENTS FOR IN VITRO USE IN BIOCHEMISTRY, CLINICAL CHEMISTRY AND MICROBIOLOGY; MEDIA FOR BACTERIOLOGICAL CULTURES, NAMELY, CHEMICALLY DEFINED MEDIA SUPPLEMENTS FOR THE GROWTH OF BACTERIA, VIRAL OR ANIMAL CELLS IN CULTURE; PHARMACEUTICAL PREPARATIONS DERIVED FROM PLASMA AND RECOMBINANT DNA TECHNOLOGY FOR THE PREVENTION AND/OR TREATMENT OF BLOOD DISORDERS; BLOOD PRODUCTS, NAMELY, PLASMA VOLUME EXPANDERS, HUMAN ALBUMIN, BLOOD CLOTTING FACTORS AND IMMUNOGLOBULINS FOR MEDICAL AND CLINICAL USE; TEST KITS CONSISTING PRIMARILY OF CLINICAL DIAGNOSTIC REAGENTS AND BLOOD PLASMA; MEDIA FOR BACTERIOLOGICAL CULTURES FOR MEDICAL PURPOSES
- Class 010 — Medical apparatus: DEVICES AND INSTRUMENTS FOR THE ADMINISTRATION AND DELIVERY OF PHARMACEUTICAL PREPARATIONS FOR USE IN THE HUMAN IMMUNE DISORDERS AND HUMAN IMMUNE SYSTEM
- Class 040 — Treatment of materials: FRACTIONATION OF PLASMA TO OBTAIN INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF DIFFERENT PHARMACEUTICAL PRODUCTS; TREATMENT OF HUMAN BIOLOGICAL PRODUCTS, NAMELY, CUSTOM MANUFACTURING AND FRACTIONATION OF BLOOD AND PLASMA
- Class 042 — Scientific and technological services: HEALTH AND HYGIENE CARE, NAMELY, HEALTHCARE SERVICES; SCIENTIFIC AND INDUSTRIAL RESEARCH
Owner
- ZLB BEHRING AG, BERN 22, CH
- ZLB Bioplasma AG, CH-3000 Bern 22, CH
- ZLB Bioplasma AG, CH-3000 Bern 22, CH
Prosecution history
- 08 May 2005 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 06 May 2005 — ABANDONMENT - NO USE STATEMENT FILED
- 31 Aug 2004 — SOU EXTENSION 1 GRANTED
- 18 Aug 2004 — SOU EXTENSION 1 FILED
- 18 Aug 2004 — SOU TEAS EXTENSION RECEIVED
- 14 May 2004 — PAPER RECEIVED
- 02 Mar 2004 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2003 — PUBLISHED FOR OPPOSITION
- 19 Nov 2003 — NOTICE OF PUBLICATION
- 08 Oct 2003 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Sept 2003 — CASE FILE IN TICRS
- 14 Aug 2003 — PAPER RECEIVED
- 19 May 2003 — FINAL REFUSAL MAILED
- 07 Apr 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE